Dilip G Shah, secretary-general of the Indian Pharmaceutical Alliance (IPA) and member of the Expert Review Committee on Access to Medicine (ATM), discusses the association’s commitment to assisting the Indian government with policies that ensure access to affordable medicines for all as well as the requirements that every candidate needs to meet to become a full member of IPA; a substantial R&D focus being one of the highest priorities.
Can you give our international readers an introduction to yourself and your background?
"Policymakers need to look at the industry’s issues today, and provide the clear guidance on how the government could help resolve them."
